TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
OMER

Omeros Corporation

Healthcare · Biotechnology

20.10$ -2.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement OMER
Line item 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 0.01 0.13 0.11 0.20 0.10 0.20 0.25 0.06 0.02 0.36 1.03 1.42 0.61 2.26 1.29 1.45 0.00 0.00 0.00 0.00
– – 1.82 2.35 3.01 1.46 1.42 0.00 0.64 0.80 0.03 0.03 0.02 0.01 0.05 0.03 0.02 0.02 1.11 0.02 –
– 0.01 0.13 0.11 0.20 0.10 0.20 0.25 -0.59 -0.79 0.33 0.99 1.40 0.60 2.20 -0.03 -0.02 -0.02 -1.11 -0.02 –
0.41 1.44 1.12 1.66 2.35 1.10 1.07 1.32 1.27 1.44 1.29 1.25 1.22 1.85 2.22 1.88 1.91 1.80 1.83 2.05 1.28
– 0.25 0.73 0.73 0.73 0.41 0.37 0.45 0.55 0.68 0.92 1.07 1.14 1.01 1.30 1.27 0.88 0.81 0.79 0.85 0.65
0.54 1.69 1.84 2.39 3.08 1.50 1.44 1.78 1.82 2.12 2.23 2.34 2.36 2.91 3.48 2.72 2.76 2.60 2.62 2.91 1.93
-0.54 -1.68 -1.71 -2.28 -2.88 -1.41 -1.23 -1.53 -1.77 -2.11 -1.90 -1.34 -0.96 -2.31 -1.28 -2.74 -2.78 -2.60 -2.62 -2.91 -1.93
– 0.01 0.01 0.03 0.31 0.07 0.08 0.07 0.08 0.10 0.10 0.19 0.24 0.33 0.46 0.47 0.32 0.36 0.49 0.42 0.02
-0.52 -1.60 -1.62 -2.22 -2.62 -1.29 -1.20 -1.59 -1.39 -2.22 -2.00 -1.65 -1.17 -2.88 -1.71 -3.43 -3.07 -2.90 -2.79 -3.14 -0.04
– 0.02 0.00 0.07 0.05 -0.04 0.05 0.06 0.10 0.09 0.12 0.21 0.26 -0.27 0.45 -0.41 -5.87 -3.36 -0.91 0.44 0.03
-0.52 -1.60 -1.62 -2.22 -2.92 -1.37 -1.29 -1.59 -1.39 -2.22 -2.00 -1.65 -1.17 -2.61 -1.71 -2.41 -1.79 0.76 -1.88 -2.70 -0.05
-0.52 -1.57 -1.58 -2.24 -2.55 -1.27 -1.18 -1.51 -1.30 -2.10 -1.90 -1.45 -0.92 -2.52 -1.21 -2.94 -2.73 -2.52 -2.28 -2.70 -0.03

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?